NCT06689085 - 52 Week Study of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

February 5, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

December 31, 2027

Conditions

Hypogonadism, Male

Interventions

COMBINATION_PRODUCT

Testosterone enanthate

XYOSTED 50mg, XYOSTED 75 mg, XYOSTED 100 mg

Trial Locations (13)

10467

RECRUITING

Children's Hospital at Montefiore, The Bronx

29203

RECRUITING

Prisma Health Children's Hospital - Midlands, Columbia

32207

RECRUITING

Nemours Children's Specialty Care - Jacksonville, Jacksonville

60611

RECRUITING

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

63110

RECRUITING

Washington University School of Medicine in St. Louis, St Louis

77030

RECRUITING

Texas Children's Hospital, Houston

79902

RECRUITING

MedResearch, El Paso

80045

RECRUITING

Children's Hospital Colorado, Aurora

90027

RECRUITING

Children's Hospital Los Angeles, Los Angeles

94143

RECRUITING

University of California San Francisco, San Francisco

98105

RECRUITING

Seattle Children's Hospital, Seattle

98405

RECRUITING

MultiCare Institute for Research & Innovation, Tacoma

01655

RECRUITING

University of Massachusetts Memorial Medical Center, Worcester